Fiona McPhee Selected Research

Tablets

11/2016

A phase 3, open-label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fiona McPhee Research Topics

Disease

50	Infections 05/2021 - 01/2012
28	Chronic Hepatitis C 01/2019 - 01/2012
18	Fibrosis (Cirrhosis) 01/2019 - 09/2012
5	Headache (Headaches) 06/2014 - 03/2012
4	Hepatitis C 01/2016 - 01/2012
4	Diarrhea 06/2014 - 03/2012
2	Viremia 05/2021 - 01/2021
2	Liver Diseases (Liver Disease) 10/2019 - 05/2016
2	Anemia 03/2016 - 01/2016
2	Exanthema (Rash) 03/2016 - 01/2016
2	Fever (Fevers) 06/2014 - 01/2014
2	Nasopharyngitis 06/2014 - 04/2013
2	Virus Diseases (Viral Diseases) 04/2013 - 01/2013
1	Coinfection 05/2021
1	Reinfection 01/2021
1	Hepatitis E 10/2020
1	Hepatocellular Carcinoma (Hepatoma) 09/2018
1	Chronic Hepatitis B 09/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2018
1	Jaundice (Icterus) 03/2018
1	Nausea 03/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2015
1	Alopecia (Baldness) 01/2014
1	Hyperbilirubinemia 04/2013

Drug/Important Bio-Agent (IBA)

42	daclatasvirIBA 01/2019 - 03/2012
32	Ribavirin (Virazole)FDA LinkGeneric 01/2019 - 01/2012
26	asunaprevirIBA 09/2018 - 03/2012
14	InterferonsIBA 09/2018 - 03/2012
13	RNA (Ribonucleic Acid)IBA 05/2021 - 01/2012
13	Antiviral Agents (Antivirals)IBA 05/2021 - 01/2012
13	Protease Inhibitors (Protease Inhibitor)IBA 12/2020 - 04/2012
9	8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA 09/2018 - 02/2014
8	SofosbuvirIBA 01/2019 - 01/2014
4	telaprevirIBA 03/2016 - 01/2014
4	peginterferon alfa-2a (Pegasys)FDA Link 01/2016 - 09/2012
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2018 - 06/2014
3	Transaminases (Aminotransferases)IBA 03/2018 - 03/2012
2	DNA (Deoxyribonucleic Acid)IBA 05/2021 - 09/2018
2	Alanine Transaminase (SGPT)IBA 03/2018 - 06/2014
2	Proteins (Proteins, Gene)FDA Link 05/2016 - 05/2015
2	SimeprevirIBA 02/2016 - 01/2016
2	peginterferon lambda-1aIBA 01/2016 - 09/2013
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 02/2014 - 01/2014
1	Immunoglobulin M (IgM)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Viral RNAIBA 10/2020
1	entecavir FDA Link 09/2018
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2018
1	Amino Acids FDA Link 12/2016
1	TabletsIBA 11/2016
1	Interferon-alpha (Interferon Alfa)IBA 11/2016
1	NucleotidesIBA 05/2016
1	Hemoglobins (Hemoglobin)IBA 03/2016
1	sofosbuvir drug combination ledipasvirIBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	N 30IBA 06/2015
1	Interferon LambdaIBA 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	p21-Activated KinasesIBA 01/2015
1	Complement System Proteins (Complement)IBA 01/2015
1	Complementary DNA (cDNA)IBA 01/2015
1	GlucocorticoidsIBA 01/2015
1	Small Interfering RNA (siRNA)IBA 01/2015
1	EnzymesIBA 03/2014
1	BMS-605339IBA 03/2014
1	NucleosidesIBA 02/2014
1	InterleukinsIBA 02/2014
1	peginterferon alfa-2b (Pegintron)FDA Link 01/2014
1	Peptide Hydrolases (Proteases)FDA Link 04/2013
1	Monoclonal AntibodiesIBA 01/2013
1	LigandsIBA 01/2013
1	NivolumabIBA 01/2013

Therapy/Procedure

17	Therapeutics 10/2019 - 01/2012
1	Liver Transplantation 05/2016
1	Aftercare (After-Treatment) 01/2016
1	Retreatment 01/2016
1	Duration of Therapy 02/2015